Research on zero-valent p-block elements is a recent hot topic in synthetic and theoretical chemistry because of their novel electronic states having two lone pairs in both the s- and p-orbitals. It is considered that σ-donating ligands bearing large substituents are essential to stabilize these species. Herein, we propose a new approach using butadiene as a 4π-electron donor to stabilize zero-valent group 14 elements. During our study to explore the coordination chemistry of stannacyclopentadienyl ligands, unexpected products, in which the tin atom is coordinated by a butadiene in a η(4)-fashion, were obtained. Because butadiene is a neutral 4π-electron donating ligand, the formal oxidation number of the tin atoms of the products should be zero, which is supported by X-ray diffraction analysis and theoretical calculations. A mechanism for the formation of the products is also described.
Reduction of THF-stabilized plumbacyclopentadienylidene with lithium afforded dilithioplumbole. On the other hand, oxidation of the dilithioplumbole provided the starting plumbacyclopentadienylidene. This is the unprecedented example of a reversible interconversion between group 14 M(II) and its dianionic species bearing organic substituents.
A new possibility of a Rh(I) complex is demonstrated. An inverted sandwich Rh(I) complex bearing a dianionic plumbole ligand was synthesized by the reaction a dilithioplumbole with [Rh(cod)Cl] 2 . The plumbole ligand functions as a π-donor stronger than the cyclopentadienyl ligand, as evidenced by quantum-chemical calculations. The Rh(I)−plumbole complex can be applied as a catalyst for an intramolecular [2+2+2] cycloaddition reaction of a triyne.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.